Literature DB >> 19115826

Influence of culture medium on smooth muscle cell differentiation from human bone marrow-derived mesenchymal stem cells.

Zhaodi Gong1, Geoffrey Calkins, Ee-chun Cheng, Diane Krause, Laura E Niklason.   

Abstract

Human bone marrow-derived mesenchymal stem cells (hMSCs) represent an appealing source of smooth muscle cells (SMCs) for engineering small-diameter vascular grafts due to the limited availability and replicative capacity of somatic SMCs. However, lack of standardization of hMSC culture conditions has limited some progress in hMSC research. Because, at the moment, a chemically defined, serum-free medium without growth factors is not capable of amplifying hMSCs in vitro, the usage of serum (either human serum or fetal bovine serum [FBS]) continues in hMSC research. The emergence of commercial hMSCs and hMSC media opened a series of questions regarding the compatibility of commercial and homemade hMSCs and hMSC media. In this study, two types of commonly used FBS-containing hMSC media-MSCGM (containing 10% FBS) and MesenPro (containing 2% FBS), along with our homemade medium (low-glucose Dulbecco's modified Eagle's medium plus 10% selected lot FBS)-were compared in their ability to support SMC differentiation from hMSCs. The effects of FBS level, medium supplements (ascorbic acid, copper, etc.), and growth factors (transforming growth factor beta1) were also examined for their impact on SMC differentiation. It was discovered that MesenPro and transforming growth factor beta1 are the strongest SMC inducers from hMSCs. In contrast, hMSCs grown in homemade (10% Dulbecco's modified Eagle's medium) and commercial MSCGM media remained undifferentiated. FBS concentration did not affect SMC differentiation when 10% FBS was compared with 2%. Finally, the mechanism underlying SMC differentiation from hMSCs grown in FBS-containing medium was explored by following the expression changes of serum response factor during the establishment of hMSC culture.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19115826      PMCID: PMC2716410          DOI: 10.1089/ten.tea.2008.0161

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  35 in total

1.  Functional tissue-engineered blood vessels from bone marrow progenitor cells.

Authors:  Jin Yu Liu; Daniel D Swartz; Hao Fan Peng; Sylvia F Gugino; James A Russell; Stelios T Andreadis
Journal:  Cardiovasc Res       Date:  2007-05-04       Impact factor: 10.787

2.  Morphologic and mechanical characteristics of engineered bovine arteries.

Authors:  L E Niklason; W Abbott; J Gao; B Klagges; K K Hirschi; K Ulubayram; N Conroy; R Jones; A Vasanawala; S Sanzgiri; R Langer
Journal:  J Vasc Surg       Date:  2001-03       Impact factor: 4.268

3.  Serum response factor-dependent regulation of the smooth muscle calponin gene.

Authors:  J M Miano; M J Carlson; J A Spencer; R P Misra
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

4.  Transforming growth factor-beta induction of smooth muscle cell phenotpye requires transcriptional and post-transcriptional control of serum response factor.

Authors:  Karen K Hirschi; Lihua Lai; Narasimhaswamy S Belaguli; David A Dean; Robert J Schwartz; Warren E Zimmer
Journal:  J Biol Chem       Date:  2001-12-11       Impact factor: 5.157

5.  Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality.

Authors:  Ichiro Sekiya; Benjamin L Larson; Jason R Smith; Radhika Pochampally; Jian-Guo Cui; Darwin J Prockop
Journal:  Stem Cells       Date:  2002       Impact factor: 6.277

6.  The serum response factor coactivator myocardin is required for vascular smooth muscle development.

Authors:  Shijie Li; Da-Zhi Wang; Zhigao Wang; James A Richardson; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-16       Impact factor: 11.205

7.  Human arteries engineered in vitro.

Authors:  J Andrew McKee; Soma S R Banik; Matthew J Boyer; Nesrin M Hamad; Jeffrey H Lawson; Laura E Niklason; Christopher M Counter
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

8.  SM22alpha: the novel phenotype marker of injured glomerular epithelial cells in anti-glomerular basement membrane nephritis.

Authors:  Asa Ogawa; Minoru Sakatsume; Xingzhi Wang; Yunichi Sakamaki; Yutaka Tsubata; Bassam Alchi; Takeshi Kuroda; Hiroshi Kawachi; Ichiei Narita; Fujio Shimizu; Fumitake Gejyo
Journal:  Nephron Exp Nephrol       Date:  2007-05-22

9.  Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs).

Authors:  Zhaodi Gong; Laura E Niklason
Journal:  FASEB J       Date:  2008-01-16       Impact factor: 5.191

10.  Serum response factor is crucial for actin cytoskeletal organization and focal adhesion assembly in embryonic stem cells.

Authors:  Gerhard Schratt; Ulrike Philippar; Jürgen Berger; Heinz Schwarz; Olaf Heidenreich; Alfred Nordheim
Journal:  J Cell Biol       Date:  2002-02-11       Impact factor: 10.539

View more
  29 in total

Review 1.  Smooth muscle and other cell sources for human blood vessel engineering.

Authors:  Sumati Sundaram; Laura E Niklason
Journal:  Cells Tissues Organs       Date:  2011-10-25       Impact factor: 2.481

2.  Engineered vascularized bone grafts.

Authors:  Olga Tsigkou; Irina Pomerantseva; Joel A Spencer; Patricia A Redondo; Alison R Hart; Elisabeth O'Doherty; Yunfeng Lin; Claudia C Friedrich; Laurence Daheron; Charles P Lin; Cathryn A Sundback; Joseph P Vacanti; Craig Neville
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-02       Impact factor: 11.205

3.  The effects of mechanical stimulation on controlling and maintaining marrow stromal cell differentiation into vascular smooth muscle cells.

Authors:  Raphael Yao; Joyce Y Wong
Journal:  J Biomech Eng       Date:  2015-01-26       Impact factor: 2.097

Review 4.  3D bioprinting of vascular conduits for pediatric congenital heart repairs.

Authors:  Wenhan Lee; Yi Hong; Guohao Dai
Journal:  Transl Res       Date:  2019-04-11       Impact factor: 7.012

5.  Smooth-muscle-like cells derived from human embryonic stem cells support and augment cord-like structures in vitro.

Authors:  Elaine Vo; Donny Hanjaya-Putra; Yuanting Zha; Sravanti Kusuma; Sharon Gerecht
Journal:  Stem Cell Rev Rep       Date:  2010-06       Impact factor: 5.739

6.  Characterization of sequential collagen-poly(ethylene glycol) diacrylate interpenetrating networks and initial assessment of their potential for vascular tissue engineering.

Authors:  Dany J Munoz-Pinto; Andrea Carolina Jimenez-Vergara; Tanmay P Gharat; Mariah S Hahn
Journal:  Biomaterials       Date:  2014-11-27       Impact factor: 12.479

7.  Platelet-derived growth factor receptor beta identifies mesenchymal stem cells with enhanced engraftment to tissue injury and pro-angiogenic property.

Authors:  Shan Wang; Miaohua Mo; Jinmei Wang; Sobia Sadia; Bihua Shi; Xiaobing Fu; Lin Yu; Edward E Tredget; Yaojiong Wu
Journal:  Cell Mol Life Sci       Date:  2017-09-19       Impact factor: 9.261

8.  Transforming growth factor-β and smooth muscle differentiation.

Authors:  Xia Guo; Shi-You Chen
Journal:  World J Biol Chem       Date:  2012-03-26

9.  Engineering biological-based vascular grafts using a pulsatile bioreactor.

Authors:  Angela H Huang; Laura E Niklason
Journal:  J Vis Exp       Date:  2011-06-14       Impact factor: 1.355

10.  Differentiation of adult stem cells into smooth muscle for vascular tissue engineering.

Authors:  Lisa J Harris; Hamid Abdollahi; Ping Zhang; Stephen McIlhenny; Thomas N Tulenko; Paul J DiMuzio
Journal:  J Surg Res       Date:  2009-09-04       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.